Tian Ruixiang Holdings Ltd is an insurance brokers business based in the US. Tian Ruixiang shares (TIRX) are listed on the NASDAQ and all prices are listed in US Dollars. Tian Ruixiang employs 64 staff and has a trailing 12-month revenue of around 0.00.
Our top pick for
Long-term investors
Our top pick for
Beginners
Our top pick for
Active traders
| Latest market close | $1.23 |
|---|---|
| 52-week range | $1.25 - $103.87 |
| 50-day moving average | $2.05 |
| 200-day moving average | $7.65 |
| Wall St. target price | N/A |
| PE ratio | 15.5556 |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | $0.08 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $1.23 from 2022-01-21
| 1 week (2022-01-14) | -8.89% |
|---|---|
| 1 month (2021-12-23) | -21.66% |
| 3 months (2021-10-22) | -61.20% |
| 6 months (2021-07-23) | -69.33% |
| 1 year (2021-01-20) | N/A |
|---|---|
| 2 years (2020-01-20) | N/A |
| 3 years (2019-01-20) | N/A |
| 5 years (2017-01-20) | N/A |
Valuing Tian Ruixiang stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Tian Ruixiang's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Tian Ruixiang's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 16x. In other words, Tian Ruixiang shares trade at around 16x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
However, Tian Ruixiang's P/E ratio is best considered in relation to those of others within the insurance brokers industry or those of similar companies.
Tian Ruixiang's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $471,870.
The EBITDA is a measure of a Tian Ruixiang's overall financial performance and is widely used to measure a its profitability.
To put Tian Ruixiang's EBITDA into context you can compare it against that of similar companies.
| Revenue TTM | $4.2 million |
|---|---|
| Operating margin TTM | 11.07% |
| Gross profit TTM | $3.2 million |
| Return on assets TTM | 2.03% |
| Return on equity TTM | 3.62% |
| Profit margin | 11.15% |
| Book value | $2.29 |
| Market capitalisation | $16.2 million |
TTM: trailing 12 months
We're not expecting Tian Ruixiang to pay a dividend over the next 12 months.
You may also wish to consider:
Tian Ruixiang Holdings Ltd, through its subsidiaries, operates as an insurance broker in China. The company distributes a range of insurance products, including property and casualty insurance, such as automobile insurance, commercial property insurance, liability insurance, and accidental insurance; and life insurance comprising individual and group life insurances. It serves individual or institutional customers. Tian Ruixiang Holdings Ltd was founded in 2010 and is headquartered in Beijing, China. .
While there are no known plans to expand the acceptance of Doge to its cars, customers can already buy a Tesla with Bitcoin.
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
Monie offers 5% APY on deposits, but funds aren’t insured and the interface is buggy.
We’ve rounded up stats on some of the most popular COVID test stocks, along with information on how they compare and how to invest.
Buffett’s Berkshire Hathaway may now be on its way to becoming the next trillion-dollar company.
Record vehicle deliveries cause the Tesla stock price to move close to all-time highs.
Everything we know about the Affinia Therapeutics IPO, plus information on how to buy in.
Everything we know about the Austin Gold IPO, plus information on how to buy in.
Everything we know about the VinFast IPO, plus information on how to buy in.
Everything we know about the Nexalin Technology IPO, plus information on how to buy in.